COVID-19’s Biological Politics

[eagle1462010]

MORE ON GILEAD SCIENCES – THE CORPORATION BEHIND THE TREATMENT FOR CORONAVIRUS

(SECOND article in a series) The Convergence of circumstances and facts is awfully difficult to ignore.

politicalmoonshine.com

 

[badger2]

Thanks for your contributions, Eagle, we will take a closer look but first we must post another entry that links to the snake meat thread where, before it was closed down, we had linked Trump’s osteopath to COVID-19/dengue autopsies via bone morphogenetic protein. That similarity also comes through when we question mask wearing and increased CO2, and surprisingly, an antibody link as well:

HIF1 / Antibody-Dependent Dengue

Hypoxia enhances antibody-dependent dengue virus infection - PubMed

Dengue virus (DENV) has been found to replicate in lymphoid organs such as the lymph nodes, spleen, and liver in post-mortem analysis. These organs are known to have low oxygen levels (~0.5-4.5% O₂) due to the vascular anatomy. However, how physiologically low levels of oxygen affect...

www.ncbi.nlm.nih.gov

‘....Our findings indicate that the increase in viral burden associated with secondary DENV infection is antibody-dependent but hypoxia induced and suggest a role for targeting hypoxia-induced factors for anti-dengue therapy.’

 

[badger2]

The first thing we notice about fact sets in post #21, is that, on the snake meat thread, we have already shown that in nature, the Coronavirus genome can integrate retro viral elements, in particular, env. If one were to enhance COVID-19, it would be at the same location now targeted by Trump’s and Christie’s med, REGN-COV2: the RBD (receptor binding domain).

May 2020 C19 RBD

Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism - PubMed

The spread of COVID-19 caused by the SARS-CoV-2 outbreak has been growing since its first identification in December 2019. The publishing of the first SARS-CoV-2 genome made a valuable source of data to study the details about its phylogeny, evolution, and interaction with the host...

www.ncbi.nlm.nih.gov

‘....No major divergence of the interaction interface of SARS-COV-2 with hACE2 was noticed from the similarity matrix analysis. This suggests that the molecular elements required for the binding with the receptor might also be involved in the interaction with other orthologous forms of ACE2 and that these elements are not optimized specifically for the human form. Therefore, it is unlikely that the interface of RBD from SARS-COV-2 is a result of human intervention via genetic engineering aiming to increase the affinity toward ACE2.’

 

[badger2]

Post #21 on Soros involvement in Gilead mentions....’an outbreak in China whereby a Washington State doctor just used Gilead’s Remdesivir to demonstrate the first likely effective treatment.’

This is not so, but if Soros was watching, the first effective treatment(s) in spite of fits and starts, was Raoult’s French approach and Zelenko’s mimicking that and also adding zinc. Soros would have been watching the developments of Regeneron for Trump’s and Christie’s REGN technology, especially since the Palm trial for Ebola (REGN-EB3). That’s likely why Soros dropped Gilead. He would also eventually come to know that the double-antibody molecular clamp of REGN-COV2 would neutralize even those viruses in nature that would arise.







In post #19, the case for masks includes an Annals of Internal Medicine study in China: ‘another explanation is that mask wearing to prevent infection was mandatory in public settings but not in households during the study period....patients with COVID-19 who had more severe symptoms had a higher transmission capacity.’

Firstly, SARS-COV outbreaks have taught the C19 genome about mask wearing, and has done so precisely in an endemic Chinese situation. On the other hand, the mutation occurring in Germany also had comparable symptoms. What were they?

 

[badger2]

No, the Palm Trial was in 2018, Soros dropped Gilead in the second quarter of 2014.

 

[badger2]

While searching back to 2014, we came upon a kickback suit:

United States Files Suit Against Drug Manufacturer Regeneron for Paying Kickbacks Through Co-Pay Foundation

United States Files Suit Against Drug Manufacturer Regeneron for Paying Kickbacks Through Co-Pay Foundation

BOSTON – The U.S. Attorney’s Office announced today that the government has filed a civil False Claims Act complaint against drug manufacturer Regeneron Pharmaceuticals, Inc. (Regeneron), of Tarrytown, N.Y. The complaint alleges that Regeneron paid tens of millions of dollars in kickbacks for...

www.justice.gov

 

[badger2]

We searched back in an attempt to find out why Soros quit Regeneron in the second quarter of 2014, with no results at this time. However, Regeneron began a six-month project for Ebola, and in Aug 2014 coupled with BARDA. Regeneron knew that since 2006, Marburg and Ebola had been classified as material threats, but it is unknown just how soon after the 2013-2014 outbreak Regeneron began this Ebola Project.

What is known, is that Fauci’s COVID-19 mutation, D614G links to Ebola:

Ebola D759G Replication Advantage

Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity - PubMed

Sequencing of Ebola virus (EBOV) genomes during the 2014-2016 epidemic identified several naturally occurring, dominant mutations potentially impacting virulence or tropism. In this study, we characterized EBOV variants carrying one of the following substitutions: A82V in the glycoprotein (GP)...

www.ncbi.nlm.nih.gov

‘....D759G in the RNA-dependent RNA polymerase conferred a replication advantage in monkey Vero E6, human A549, and insectivorous bat Tb1.Lu cells.’

Tb1.Lu likely denotes the genus Tadarida, and Lu may be a geographical designate.

 

[badger2]

It is interesting to note that the sources for the above D759G mutation include the Special Pathogens Program, Public Health Agency of Canada, Winnipeg; Guandong Key Laboratory, Southern University of Science and Technology, Shenzhen, China; Center for Influenza Research and Early Warning, Chinese Academy of Science and Technology, Beijing.

We have already mentioned this Shenzhen location in the snake meat thread.

 

[badger2]

The politics are indeed biological, as Trump’s antibodies confront Fauci’s anger:

“They did this without my permission.”
https://www.yahoo.com/huff post/Anthony-Fauci-says-he-didnt-consent-to-Trump-ad-200524280.html

The Ebola mutation in Tb1.Lu cells above, seems to have taken place in Tadarida brasiliensis Mexicana lung cells.

Tb1.Lu (NBL-12) Sigma-Aldrich

TB1 Lu (NBL-12) CB_90020805

TB1 Lu (NBL-12) 90020805

www.sigmaaldrich.com

‘....adult female bat lung....rabies virus....’

The Sigma-Aldrich page does not name the bat species. Further tracking T. Brasiliensis links to an Appalachian Coronavirus:

Tadarida brasiliensis / Human Coronavirus (HCOV) NL63

Bat coronavirus in Brazil related to appalachian ridge and porcine epidemic diarrhea viruses - PubMed

Bat coronavirus in Brazil related to appalachian ridge and porcine epidemic diarrhea viruses

www.ncbi.nlm.nih.gov

‘....Evidence suggests that alphacoronaviruses may use bats as hosts to spread human Coronavirus which originated by evolution of Appalachian Ridge CoV strain 2 (ARCoV2).’

 

[badger2]

https://www.yahoo.com/huffpost/Anthony-Fauci-says-he-didnt-consent-to-Trump-ad-200524280.html

 

[badger2]

The Fauci report is titled ‘ Anthony Fauci Says He Didn’t Consent to Trump Ad That Takes His Words Out of Context’

 

[badger2]

Continuing the report in post #29 for the human Coronavirus links to Reynoldsburg, Ohio precisely as Ebola was taking off in Africa:

‘....In summary, we found that a CoV detected in Tadarida brasiliensis in Brazil has close phylogenetic relationships to ARCoV2 and PEDV.’

2014 Reynoldsburg, Ohio / PEDV
https:// www.ncbi.nlm.nih.gov/pubmed/24750580
‘....In Jan 2014, samples from pigs with unique disease, suspected to be PED were submitted to this laboratory.’

The high number of American deaths due to COVID-19 may link and be due to Appalachian Ridge Coronavirus and PEDV for the evolution of coronaviruses in Tadarida brasiliensis, which bat links the D759G Ebola mutation.

 

[badger2]

New variant of porcine epidemic diarrhea virus, United States, 2014 - PubMed

New variant of porcine epidemic diarrhea virus, United States, 2014

www.ncbi.nlm.nih.gov

 

[badger2]

Post #27 shows that the Ebola virus mutation D759G that happens in both human and Tadarida cells is precisely remdesivir’s target, RNA-dependent RNA polymerase.

 

[eagle1462010]

Post #21 on Soros involvement in Gilead mentions....’an outbreak in China whereby a Washington State doctor just used Gilead’s Remdesivir to demonstrate the first likely effective treatment.’

This is not so, but if Soros was watching, the first effective treatment(s) in spite of fits and starts, was Raoult’s French approach and Zelenko’s mimicking that and also adding zinc. Soros would have been watching the developments of Regeneron for Trump’s and Christie’s REGN technology, especially since the Palm trial for Ebola (REGN-EB3). That’s likely why Soros dropped Gilead. He would also eventually come to know that the double-antibody molecular clamp of REGN-COV2 would neutralize even those viruses in nature that would arise.

And yet HCL is a pathway for Zinc as well to help fight the virus.........Gilead is pushing a drug that was Federally funded.........Over a half a year ago I posted that information from souces like UAB and others doing studies on these very drugs..................but the initial studies weren't so great..........and Gilead was trying to ditch HCL from the start to PUSH IT'S DRUG.

Gilead then pushed it to Orphan status to make money...........then dropped it after being called out for it as 'Gov't funded.

Gilead is a HEAVY LOBBYIST to make tons of money........and have been tied to the likes of Rumsfield, Bush, Clinton and others..........aka they bribe politicians to create laws and rules to make them rich.

UAB begins clinical trial of COVID drug given to Trump Newer trial.............but they did the trials for ebola.

Good results for COVID-19 drug with Alabama ties

The New England Journal of Medicine published an article describing improvement for most patients in a small group taking remdesivir, which was developed through research centered at the University of Alabama at Birmingham

www.al.com

 

[badger2]

When we link Ebola to Remdesivir we get an American Coronavirus that links to COVID-19, though there is little information on its biology. It would not be so important had Fauci not led us to it.

 

[badger2]

Yes, we have already said on the now closed snake meat thread that they have done trials for Ebola. We have already begun a new thread to deal with USMB fascism and this thread is about biological politics that are more interested in why so many American deaths rather than why or how Gilead made money. Find info on Appalachian Ridge Coronavirus, because isis American, not Chinese.

 

[badger2]

That stocks can fall is mirrored here for Regeneron, though the question boils down to the biological politics between the antibody and the coronavirus. What does the CDC know about Appalachian Ridge Coronavirus? This virus is endemic to the United States and uses the same Remdesivir target as does COVID-19. Are males more susceptible? What is its history? Does Regeneron know that it links to its Ebola antibody technology?

Regeneron

https://www.yahoo.com/news/Regeneron-ceo-says-more-testing-034230468.html

 

[badger2]

The title to search for is ‘Regeneron CEO Says More Testing Needed for Antibody Cocktail After Trump Touted it as COVID-19 ‘Cure’. We are fortunate, thanks to Fauci, to finally address the question of the Ebola reservoir in nature at the same time as the question of the COVID-19 reservoir in nature.

 

[badger2]

We begin to analyze Fauci’s COVID-19 mutation as it occurs in Ebola virus. Note that within these months, Soros decided to drop Regeneron.

Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak - PubMed

The dimension of the Ebola virus outbreak in West Africa was unprecedented. Amino acid substitutions in the viral L polymerase, surface glycoprotein GP, and nucleocapsid protein NP emerged, were fixed early in the outbreak, and were found in almost 90% of the sequences. Here we showed that these...

www.ncbi.nlm.nih.gov

‘....The first substitution, an exchange from aspartame to glycine, was located at amino acid position 759 of the L polymerase in close vicinity to the highly conserved GDN motif of the enzymatically active center (amino acids 741 to 743).
....Fig.2 Row 1, amino acid mutations at NP111, GP82, and L759; Row 2, incidence of the three different mutations in 1,011 full viral genome sequences from EBOV cases that occurred between Mar 2014 and Oct 2015; Row 3, date of the first appearance of mutations at positions NP111, GP82, and L759 and the respective GenBank accession numbers. From Mar to Jun the majority of sequences had the signature of the prototype Makona C7 (69%). Sequences with the single mutation L759D were reported for a short time period (until Ap 2014). Until end of May 2014, the double mutant GP A82V and L D759G coexisted before the triple mutation became the dominant signature in the following months until the end of the outbreak. The three mutants accumulated sequentially in the order L D759G > GP A82V > NP R111C.’